MICHELLE VALENCIA: Open Payments
NPI 1972377828 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 68 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $946 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $231 |
| ABBVIE INC. | 12 | $158 |
| Amgen Inc. | 15 | $151 |
| Novo Nordisk Inc | 8 | $141 |
| GlaxoSmithKline, LLC. | 5 | $104 |
| Corcept Therapeutics | 4 | $100 |
| Lilly USA, LLC | 8 | $93 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| PFIZER INC. | 3 | $61 |
| Exact Sciences Corporation | 2 | $35 |
Products named: AIRSUPRA, OTEZLA, TRELEGY ELLIPTA, Korlym, MOUNJARO, Wegovy, VRAYLAR, LEQVIO.
Industry payments across TX — which companies pay providers there.
